Skip to main content
Clinical Trials/NCT04379752
NCT04379752CompletedNot Applicable

Using Indirect Cold Atmospheric Pressure Plasma (Plasma Activate Liquid) for the Treatment of Hair Loss

Dr. Peter C. Friedman2 sites in 1 country14 target enrollmentStarted: July 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
14
Locations
2
Primary Endpoint
Presence of detectable hair growth

Study Overview

Brief Summary

Self applied cold plasma activated medium used for androgenetic alopecia

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • diagnosis of mild-to moderate androgenetic alopecia
  • ability of applying treatment regularly
  • ability to keep in-person follow-up appointments

Exclusion Criteria

  • any inflammatory scalp condition
  • starting or discontinuing any hair loss treatments within 6 months of start date
  • allergy to any components of the carrier solution

Outcomes

Primary Outcomes

Presence of detectable hair growth

Time Frame: 3 months and 6 months

Presence of hair growth is observed clinically. Evaluation may include photo comparison, hair count, trichoscopy

Secondary Outcomes

  • Adverse effects related to the treatment(throughout study completeion, 6 months)

Investigators

Sponsor
Dr. Peter C. Friedman
Sponsor Class
Industry
Responsible Party
Sponsor Investigator
Principal Investigator

Dr. Peter C. Friedman

President

The Skin Center Dermatology Group

Study Sites (2)

Loading locations...

Similar Trials